NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/10/2025
Back to search
Official data from USPTO
VERAX BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VERAX BIOMEDICAL
ST13
US500000076509347Class
16
Filing
76509347
Registration
2892711
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
03/04/2025
Trademark type
Word
Nice classes
16
Filing date
04/25/2003
Registration date
10/12/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2025
Last transaction
03/04/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/05/2001
First use in commerce
11/05/2001
Drawing code
1
Owner type
03
Owner location
Marlborough, MA
Examiner
KEATING, MICHAEL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
V. I. (pessoa física)
V. I. (pessoa física)
Representatives
Emilia F. Cannella ROPES & GRAY LLP
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed mattermeeting abstractsposter presentationsnewsletterspamphletsbrochuresproduct guidesproduct instructions relating to health and safety
Publications
History of USPTO decisions and trademark events.
24 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/10/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
10/15/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/12/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/02/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/02/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/02/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
09/22/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/05/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/05/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/16/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/15/2010
E815
TEAS SECTION 8 & 15 RECEIVED
11/01/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
10/12/2004
PUBO
PUBLISHED FOR OPPOSITION
07/20/2004
NPUB
NOTICE OF PUBLICATION
06/30/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2004
PAPER RECEIVED
04/13/2004
CNRT
NON-FINAL ACTION MAILED
10/28/2003
DOCK
ASSIGNED TO EXAMINER
10/27/2003
Continuous trademark protection
Get notified about every new filing that threatens VERAX BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.